Cogent Biosciences (COGT) Change in Cash: 2017-2021
Historic Change in Cash for Cogent Biosciences (COGT) over the last 5 years, with Dec 2021 value amounting to $16.8 million.
- Cogent Biosciences' Change in Cash fell 85.11% to $16.8 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$22.5 million, marking a year-over-year decrease of 110.99%. This contributed to the annual value of $44.9 million for FY2024, which is 151.11% up from last year.
- Cogent Biosciences' Change in Cash amounted to $16.8 million in Q4 2021, which was up 210.38% from -$15.2 million recorded in Q3 2021.
- In the past 5 years, Cogent Biosciences' Change in Cash registered a high of $112.8 million during Q4 2020, and its lowest value of -$15.2 million during Q3 2021.
- For the 3-year period, Cogent Biosciences' Change in Cash averaged around $13.7 million, with its median value being -$8.0 million (2020).
- As far as peak fluctuations go, Cogent Biosciences' Change in Cash tumbled by 497.02% in 2019, and later soared by 1,433.29% in 2020.
- Over the past 5 years, Cogent Biosciences' Change in Cash (Quarterly) stood at -$2.4 million in 2017, then skyrocketed by 371.28% to $6.4 million in 2018, then plummeted by 232.67% to -$8.5 million in 2019, then spiked by 1,433.29% to $112.8 million in 2020, then plummeted by 85.11% to $16.8 million in 2021.
- Its Change in Cash stands at $16.8 million for Q4 2021, versus -$15.2 million for Q3 2021 and -$12.6 million for Q2 2021.